Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors

NCT01648465 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Tumors
Pancreatic Tumors
Gastrointestinal Neuroendocrine Tumors
Pancreatic Neuroendocrine Tumors

Interventions

DRUG: Everolimus

Sponsor

Hellenic Cooperative Oncology Group

Collaborators

[object Object]